Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

Abstract

First study concerning the effect of incretine analogue liraglutid in obese patents without diabetes. Liraglutide reduced significantly body weight without any risk of hypoglycemia.

Keywords

• Obesity
• incretine analogue
• prediabetes